FDA Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products
Titel:
FDA Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products
Internet:
Herkunft/Verlag:
FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM338856.pdf
Inhalt:
Bewertung immunologischer Nebenwirkung von therapeutischen Proteinen